Chile In-Vitro Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented by By Test Type, Product, Usability, Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease and Other Applications) and End-users

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

6.2 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

In-vitro diagnostic tests are the tests being used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes. The rising prevalence of the chronic disease has been the primary driver for the growth of this market. 

This rising prevalence has increased the demand for early and effective diagnostic tests. Rising prevalence of chronic illnesses has also increased the use of point-of-care (POC) diagnostics. Moreover, increasing awareness and acceptance of personalized medicine and companion diagnostics have also helped the market to grow.

Scope of the report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Hematology
Other Techniques
By Product
Instrument
Reagent
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Other Applications
By End-users
Diagnostic Laboratories
Hospitals & Clinics
Other End-users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Diabetes is Expected to Cover a Large Share of the Market

Diabetes is a chronic disorder resulting from insulin deficiency and hyperglycemia and has a high risk of development of complications for the eyes, kidneys, peripheral nerves, heart, and blood vessels. Quick diagnosis and early prevention are critical for the control of the disease status. 

Traditional biosensors such as glucose meters and glycohemoglobin test kits are widely used in vitro for this purpose because they are the two major indicators directly involved in diabetes diagnosis and long-term management. There has been a huge demand for these tests that make it a model disease to develop new approaches to biosensors.

The number of diabetic patients in Chile is one rise as per reports by the International Diabetes Federation (IDF). Hence this is expected to increase the overall demand for early diagnostics tests like in-vitro diagnostics test, which will help the market to grow in Chile.

To understand key trends, Download Sample Report

Competitive Landscape

Chile is a developing country and has high income as per World Bank. The market is very lucrative, due to the increasing prevalence of diseases and high purchasing power. This has made the market very lucrative, which is the reason most of the pharmaceutical multinationals are present in the country. This has made the in-vitro diagnostics market in Chile very competitive.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Other Techniques

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Other Applications

    5. 5.5 By End-users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals & Clinics

      3. 5.5.3 Other End-users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMérieux

      4. 6.1.4 Bio-Rad Laboratories, Inc.

      5. 6.1.5 F. Hoffmann-La Roche AG

      6. 6.1.6 QIAGEN N.V.

      7. 6.1.7 Siemens Healthcare GmbH

      8. 6.1.8 Sysmex Corporation

      9. 6.1.9 Thermo Fischer Scientific Inc.

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports